Skip to main content

Illumina Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

53
Companies
$983.8M
Total invested
$24.6M
Avg. check
25
Industries
Biotechnology 23Medical 10Health Care 10Life Science 6Genetics 5Biopharma 3+19 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 53
CubaseBio
September 2026

Cubase Bio is a biotechnology business that focuses on spatial biology tools.

Biotechnology · Stockholm$4.6M Grant
Robigo
September 2026

Robigo is a biomanufacturing company engineering microbes to create more sustainable crop protection solutions.

Agriculture · CambridgeSeries A
Integrated Biosciences
August 2026

Integrated Bio develops multimodal biological datasets and AI for drug discovery, focusing on therapeutics for age-related diseases.

Biopharma · Redwood City$68.4M Venture - Series Unknown
Human Longevity
August 2024

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

Biotechnology · San Diego$39.8M Series B
NuCicer
July 2025

NuCicer offers high-protein chickpea ingredients with added value in the agri-food system.

Agriculture · Davis$11.5M Series A
SyntaxBio
June 2026

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

Biotechnology · Chicago$14.4M Series A
Infinity Bio
June 2025

Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.

Biometrics · Baltimore$8.0M Series A
Arima Genomics
June 2025

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

Biotechnology · San Diego$22.0M Series C
SonoThera
June 2026

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

Biopharma · South San Francisco$125.0M Series B
Tagomics
June 2025

Tagomics transforms disease diagnosis through comprehensive multiomic profiling.

Biotechnology · Cambridge$1.2M Grant
Pluton Biosciences
May 2023

Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.

AgTech · Saint Louis$16.5M Series A
Kallyope
May 2023

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Biotechnology · New York$8.2M Grant
Biosynch.ai
April 2025

Pioneering the future of medicine through artificial intelligence and computational biology.

San Diego$4.2M Seed
Lightcast Discovery
April 2026

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

Biotechnology · Cambridge$27.0M Venture - Series Unknown
Fluent BioSciences
March 2024

Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Biotechnology · WatertownGrant
SQZ Biotech
March 2022

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Biotechnology · Watertown$2.0M Grant
Twist Bioscience
February 2022

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

B2B · San Francisco$250.0M Post-IPO Equity
Walking Fish Therapeutics
February 2022

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

Biotechnology · San Francisco$23.0M Series A
Pattern Bioscience
August 2025

Pattern Bioscience is a biotech diagnostics company that helps to combat the problem of antibiotic resistance.

Biotechnology · Austin$44.2M Venture - Series Unknown
Stilla Technologies
February 2024

Stilla Technologies is a Paris-based european biotechnology company.

Biotechnology · Villejuif$26.5M Series C
Broken String Biosciences
September 2023

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

Biotechnology · Cambridge$15.0M Series A
LetsGetChecked
January 2025

LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.

Biotechnology · Atlanta$165.0M Series F
Protillion Biosciences
December 2022

Protillion Biosciences specializes in the design and development of protein-based drugs.

Biopharma · Burlingame$18.0M Series A
Hepta Bio
November 2025

Hepta Bio detect, monitor, and direct the most effective liver treatment.

Biotechnology · San Francisco$6.7M Seed

Where Illumina Ventures invests

Biotechnology23
Medical10
Health Care10
Life Science6
Genetics5
Biopharma3

About Illumina Ventures's portfolio

How many companies has Illumina Ventures invested in?▸

Illumina Ventures has invested in 53 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Illumina Ventures invest in?▸

Illumina Ventures's top investment sectors include Biotechnology, Medical, Health Care, Life Science, Genetics. The firm invests across 25 different industry categories.

What is Illumina Ventures's largest investment?▸

Among tracked funding rounds, Twist Bioscience received $250.0M in a Post-IPO Equity round. Illumina Ventures's total known invested capital is $983.8M.

What is the average investment size for Illumina Ventures?▸

Illumina Ventures's average investment size is $24.6M across its portfolio of 53 companies.

What are Illumina Ventures's most recent investments?▸

Recent Illumina Ventures portfolio additions include CubaseBio, Robigo, Integrated Biosciences, Human Longevity, NuCicer. These companies were founded in 2020 or later.

Reach the founders behind these 53 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →